Thursday, September 18, 2025 9/18/2025

Cellular and molecular mapping of ventilator-induced lung injury

Award Number: R01HL170601
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/04/2024
PERIOD OF PERFORMANCE END DATE: 02/29/2028

Group Awards By:

View Award Description

Cellular and molecular mapping of ventilator-induced lung injury - PROJECT SUMMARY Acute respiratory distress syndrome (ARDS) is a major source of morbidity and mortality in patients ventilated for acute respiratory failure. Despite extensive study, little is known about the pathogenesis of ARDS in humans. One salient finding is that barotrauma or ventilator-associated lung injury (VALI) from high-pressure ventilation is a consistent signal for ARDS risk regardless of the underlying disease. Beyond lung protective (low pressure) ventilation, ARDS lacks specific treatments in large part due to the lack of knowledge about the cellular and molecular mechanisms of pathology. Here, we will take advantage of an established ex vivo ventilation and lung perfusion (EVLP) system to directly assess the initial cellular and molecular responses to VALI in human lung. Importantly, each individual will serve as their own control, achieved by ventilating the right and left lung under high and low pressure, respectively. Some studies will incorporate hyperoxia, elevated PEEP, or live bacteria with VALI to provide even more clinical relevance. Single cell RNA sequencing on the experimental and control lungs following ventilation will provide deep molecular profiles of alveolar cells subjected to barotrauma. This tissue-dissociative analysis will be complemented with multimodal (protein and RNA) and multiplex staining of intact lung tissue using two complementary technologies, to correlate the molecular with spatial and morphological features of pathology. We will also test the capacity of human lung to recover from acute VALI by culturing lung slice cultures at air-liquid interface following ventilation, and how this is impacted by pan and endothelial-specific Wnt inhibition, lipopolysaccharide, and targeted pathway manipulations. In summary, our studies will open a window into the dynamic cellular and molecular responses of human lung in acute lung injury.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $666,542 )
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Lung Diseases Research	000	2	4/23/2025	NON-COMPETING CONTINUATION	$599,888
2025	2025	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Lung Diseases Research	001	2	7/3/2025	NON-COMPETING CONTINUATION	$66,654
														Subtotal = $666,542

Issue Date FY: 2024 ( Subtotal = $673,194 )
2024	2024	THE LELAND STANFORD JUNIOR UNIVERSITY	450 JANE STANFORD WAY	STANFORD	CA	94305	SANTA CLARA	USA	Lung Diseases Research	000	1	3/4/2024	NEW	$673,194
														Subtotal = $673,194

Grand Total All Awards = $1,339,736

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cellular and molecular mapping of ventilator-induced lung injury

Award Number: R01HL170601

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/04/2024

PERIOD OF PERFORMANCE END DATE: 02/29/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer